Rosalind Advisors, Inc.
Gil Aharon brings extensive experience in the biotechnology and investment sectors, currently serving as the Director at Delcath Systems since May 2020. In addition to this role, Gil Aharon co-founded Rosalind Advisors, Inc. in April 2007 and continues to function as a Portfolio Manager. Academic credentials include a PhD obtained from the University of Toronto, where Gil Aharon studied from January 1998 to June 2003.
This person is not in any teams
Rosalind Advisors, Inc.
Rosalind Advisors, Inc. is a biotech investment manager. Our biotech funds’ strategy is market agnostic, operating at the intersection of science and finance with the goal of capitalizing on consistent market inefficiencies and arbitrage opportunities. Since its founding in 2006, the fund has had a consistent track-record of uncorrelated abnormal returns.